Short-Seller Quadir Targets Two Stocks, Reveals Strategy in London Talk

Fahmi Quadir, the founder and Chief Investment Officer of Safkhet Capital, described the role of a short-seller as akin to an investigative journalist during a public talk in London on 22 May 2026. Bloomberg reported on the event held at Wilton’s Music Hall, where Quadir discussed her firm's methodology and high-profile campaigns against companies like Wirecard AG and Valeant Pharmaceuticals. Safkhet Capital, known for its concentrated, high-conviction bets, has generated an annualized return of approximately 35% since its inception in 2019 by identifying corporate malfeasance and structural weaknesses. Quadir’s approach involves deep fundamental research and forensic accounting to build short positions before publicly presenting a detailed thesis.

Context — why this matters now

Activist short-selling has gained prominence as a market discipline mechanism following major corporate scandals. The collapse of German payments firm Wirecard in June 2020, after a 14-month short campaign by journalists and investors, erased over 14 billion euros in market value. The Valeant Pharmaceuticals scandal in 2015, which saw its stock price fall over 90% from its peak, involved aggressive accounting and predatory pricing practices exposed by short-sellers.

The current market environment features elevated valuations in certain sectors, particularly technology and healthcare, which can obscure underlying business risks. Corporate debt levels remain high, with the aggregate debt-to-EBITDA ratio for non-financial S&P 500 companies at 2.8x as of Q1 2026. This backdrop creates fertile ground for short-sellers who identify companies with unsustainable financial models. The catalyst for renewed focus is a recent uptick in SEC enforcement actions related to accounting irregularities, signaling regulatory scrutiny that often follows short-seller reports.

Quadir’s public discussion coincides with increased retail investor sophistication and access to short-selling instruments. Regulatory filings show short interest across US equities at 4.2% of float, near a five-year high. This indicates a market where skepticism is priced in, raising the stakes for short-sellers to present irrefutable, novel evidence. The rise of social media as a dissemination channel for investment theses has accelerated the impact of activist campaigns, compressing the timeline for price discovery.

Data — what the numbers show

Safkhet Capital's performance data highlights the asymmetric returns possible in concentrated short-selling. The firm's flagship fund has delivered an annualized return of 35% since 2019, compared to the S&P 500's annualized return of 11.2% over the same period. This performance came with significant volatility, with the fund experiencing a maximum peak-to-trough drawdown of 28% in 2023 during a broad market rally.

Metric	Safkhet Capital Fund	S&P 500 Index (Total Return)
Annualized Return (2019-2026)	35%	11.2%
Sharpe Ratio	1.4	0.8
Win Rate (Positions)	62%	N/A

Quadir’s most famous position, Wirecard AG, collapsed from a peak market capitalization of over 24 billion euros in 2018 to bankruptcy in 2020. Her fund established its short position at an average price of 150 euros per share, covering near zero, representing a near-total return on capital at risk. The Valeant Pharmaceuticals short saw the stock fall from a high of $263.70 in August 2015 to below $30 by late 2016, a decline exceeding 88%.

Current market data shows short interest in the S&P 500 healthcare sector at 5.1% of float, the highest among all eleven sectors. The information technology sector follows at 4.7%. This concentration suggests short-sellers are focusing on high-growth, high-multiple areas where expectations may outpace reality. The average holding period for a successful activist short campaign is 18 months, reflecting the patience required for a thesis to play out against potential short squeezes.

Analysis — what it means for markets / sectors / tickers

Quadir’s focus on forensic accounting and business model sustainability directly impacts sectors reliant on aggressive growth assumptions. Publicly traded companies in healthcare services, specialty pharmaceuticals, and fintech are likely to face increased scrutiny. Firms with high goodwill balances relative to tangible assets, a common red flag, may see elevated short interest. The S&P 500 Healthcare Equipment & Services sub-index trades at a forward P/E of 24x, a 30% premium to the broader market, creating a valuation gap short-sellers target.

The primary risk to this strategy is the potential for coordinated short squeezes, which can force premature covering at a loss. Regulatory changes also pose a threat, as authorities in Europe and Asia have proposed stricter disclosure rules for short positions above certain thresholds. A counter-argument is that activist short-selling can harm fundamentally sound companies through reputation damage, potentially creating buying opportunities for long-term investors if the short thesis proves flawed.

Positioning data from prime brokers indicates institutional flows into dedicated short-biased funds increased by $4.2 billion in Q1 2026. Hedge funds with a multi-strategy approach are allocating more capital to dedicated research pods focused on identifying short candidates. Flow is moving away from broad index shorts toward highly specific, thesis-driven single-name positions where the asymmetric return profile is more pronounced. This shift increases stock-specific volatility for targeted companies.

Outlook — what to watch next

Key catalysts for short-selling activity include the Q2 2026 earnings season starting in mid-July, where guidance cuts or margin compression could validate existing theses. The SEC's quarterly review of financial filings, due for release in August 2026, may highlight new areas of accounting concern. Regulatory hearings on market structure and short sale disclosure, scheduled for 10 September 2026 before the US House Financial Services Committee, could impact the operational environment for activist funds.

Market participants should monitor the CBOE Short Volatility Index (VXSHORT), which measures the cost of betting against the market. A level above 25 indicates expensive put options and potential crowding in short bets. The relative performance of low-quality versus high-quality stock factors serves as a barometer for short-seller effectiveness; a widening gap favors short-sellers targeting weak fundamentals. Key support levels for the S&P 500 are at 4,800 and 4,600; a break below these could trigger broader risk-off sentiment that benefits bearish strategies.

If interest rates remain elevated through the next FOMC meeting on 17 June 2026, highly leveraged companies will face refinancing risk, a common short thesis trigger. Conversely, a dovish pivot could spark a relief rally in heavily shorted names, forcing coverings. The performance of special purpose acquisition company (SPAC) mergers from the 2021-2022 vintage will be critical, as many represent the type of speculative, cash-burning businesses short-sellers target. Widespread failures would validate the activist approach.

Frequently Asked Questions

What is the typical holding period for a short-seller like Fahmi Quadir?